Cargando…
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910095/ https://www.ncbi.nlm.nih.gov/pubmed/36776449 http://dx.doi.org/10.2147/DDDT.S405817 |
| _version_ | 1784884715686199296 |
|---|---|
| author | Idrus, Hasta Handayani Sunarno, |
| author_facet | Idrus, Hasta Handayani Sunarno, |
| author_sort | Idrus, Hasta Handayani |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9910095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99100952023-02-10 Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] Idrus, Hasta Handayani Sunarno, Drug Des Devel Ther Letter Dove 2023-02-05 /pmc/articles/PMC9910095/ /pubmed/36776449 http://dx.doi.org/10.2147/DDDT.S405817 Text en © 2023 Idrus and Sunarno. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Idrus, Hasta Handayani Sunarno, Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title_full | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title_fullStr | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title_full_unstemmed | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title_short | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter] |
| title_sort | liquiritin protects against cardiac fibrosis after myocardial fibrosis after myocardial infarction by inhibiting ccl5 expression and the nf-κb signaling pathway [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910095/ https://www.ncbi.nlm.nih.gov/pubmed/36776449 http://dx.doi.org/10.2147/DDDT.S405817 |
| work_keys_str_mv | AT idrushastahandayani liquiritinprotectsagainstcardiacfibrosisaftermyocardialfibrosisaftermyocardialinfarctionbyinhibitingccl5expressionandthenfkbsignalingpathwayletter AT sunarno liquiritinprotectsagainstcardiacfibrosisaftermyocardialfibrosisaftermyocardialinfarctionbyinhibitingccl5expressionandthenfkbsignalingpathwayletter |